Dyne Therapeutics Inc
DYNHealthcare|Biotechnology|USA
$23.43
-0.84 (-3.48%)
Tangible Book
$5.24
Earnings Power
$4.45
About
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
Stock Price
+166.3%(1Y)
Pipeline Summary
6 total trials2
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
Recruiting: 4Active: 2
Active Trials (6)
Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)
NCT04635891FSHD
Recruiting
Enrollment: 450 participants
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
NCT03458832Facioscapulohumeral Muscular Dystrophy
Active
Enrollment: 324 participants
Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1
NCT05481879Myotonic Dystrophy Type 1 (DM1)
Phase 1Phase 2Recruiting
Enrollment: 116 participants
Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1
NCT07486934Myotonic Dystrophy Type 1 (DM1)
Phase 3Recruiting
Enrollment: 150 participants
Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO)
NCT07608432Duchenne Muscular Dystrophy (DMD)
Phase 3Recruiting
Enrollment: 90 participants
BioScore
4.6/10
Cautious
Ownership
Recent Insider Trades
Rhodes Jason PSELL
2026-07-07777,451 shares @ $22.97
Rhodes Jason PSELL
2026-06-29504,695 shares @ $21.23
Rhodes Jason PSELL
2026-06-25267,760 shares @ $21.09
Lucera ErickSELL
2026-06-252,362 shares @ $20.37
Kersten DirkSELL
2026-06-23263,962 shares @ $20.7
Recent News
2026-06-26 17:03:28
Data last updated: Jul 12, 2026, 07:38 PM